Artificial Intelligence and genomic data: Kenneth Kehl, MD, MPH| Dana-Farber Cancer Institute [Video]

Using artificial intelligence to link genomic data to clinical outcomes in cancer care across institutions without compromising protected health information is challenging.
Dana-Farber’s Kenneth Kehl, MD, MPH, discusses an approach designed to preserve patient privacy. Research presented at ASCO 24. Video published 6/7/2024